Sepsis Vaccine Proves Protective in Preliminary Studies
A group of TSRI researchers have designed a vaccine that might be used to protect against the pernicious consequences of severe sepsis, an acute and often deadly disease.








Antibodies Produce Ozone During Bacterial Killing and Inflammation

Ozone has "never been considered a part of biology before," according to TSRI President Richard Lerner. His recent study with investigator Paul Wentworth and others may change this.